Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill - Test2 - elhamkhani - TriplyDB

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill

http://www.wikidata.org/entity/Q26753102

about

Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.[Management of different cardiovascular risk factors with a combination tablet (polypill)].Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease.

P2860

Q28068965-39F486AD-ABEC-489B-B8D7-F4209CF95D9E Q30235416-6969FD38-5F39-47CE-89F0-69A9E1ABE64B Q36322893-178415AC-6A9D-4D2F-95FF-0647077FD965 Q37100330-8A661320-8BE5-4D29-8123-30EBD57F94DE

P2860

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill

http://www.wikidata.org/entity/Q26753102

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@ast

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@en

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@nl

type

label

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@ast

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@en

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@nl

prefLabel

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@ast

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@en

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@nl

P1433

Q26753102-FE8D66E7-6714-454E-91C0-93019E6A59FD

P1476

Q26753102-C8A2EC34-949D-41DE-A061-8D35637483B8

P2093

Q26753102-3E4B6D1B-5AC0-47D4-9628-80FEF9A9376E

Q26753102-6EDB0DF9-82ED-471E-8035-BD9D371DCFF6

Q26753102-A1C5D16C-5BA7-4F91-81DF-4E99AB6ECD89

P275

Q26753102-08583F90-B4AB-4CE3-B36C-724B39C40BB5

P2860

Q26753102-13232523-B1E8-4893-82B1-984AE1E26454

Q26753102-17C6ADB4-ED37-4DE6-93A1-26215EF26DC3

Q26753102-22CA4A78-9FA8-4032-9390-18C44D46E801

Q26753102-3296B9F4-4334-4E1F-8446-6135BE167172

Q26753102-335FB9FC-3FAA-44C0-9FFE-100766B170F9

Q26753102-378CF9CA-EFAB-4A28-84D7-6EA48ED14E82

Q26753102-3B09AC21-B7B6-456C-BD3E-97C62748B650

Q26753102-3CA9CD67-4272-4EBD-92FD-ECB128EFCA63

Q26753102-4071BB59-94AE-46E4-A268-31A5367E815E

Q26753102-4FE34AED-4263-4322-8ED0-A0D63850187C

P2888

Q26753102-872861C4-D8A3-4984-BA72-ABB39B7C301F

P304

Q26753102-1343F2C6-AA1B-43E8-9EE5-D121D220D473

P31

Q26753102-113F2B12-7BA4-452B-BFA3-0C5D2F9AA3D1

P3181

Q26753102-3C1DD1FC-4B69-45E0-8437-B633C29042B5

P356

Q26753102-934C59E6-6B97-43C4-B525-61DCD14272E9

P407

Q26753102-EB00A6FF-7860-4963-B4E2-DCE8E6587B65

P433

Q26753102-6451AB7F-F113-451F-868F-E434816D4ACD

P478

Q26753102-30988AC0-CD8C-4127-AC6F-5B44CA9CF622

P50

Q26753102-0F406D00-BA85-4739-AD83-A708373DDD5E

P5008

Q26753102-71C205B5-A3DD-40BE-8254-42AE16EFC624

P577

Q26753102-556BA7C5-1E8F-4CD7-A11D-D7C33A4DDC76

P6179

Q26753102-3673EAC7-A598-44FE-88F9-DEEA9F96F4BF

P698

Q26753102-FAC33BD4-A43F-4335-82B9-D510D83B2EFE

P921

Q26753102-76808A7B-29AD-40DE-BA38-995850817712

Q26753102-DBB6DE59-99D1-4346-93A2-FD9D62118330

P932

Q26753102-42F8D158-F6E3-4DEF-B2C8-755BE196DBF4

P3181

P356

S11906-016-0648-3

P1433

Current Hypertension Reports

P1476

Multifactorial Prevention of C ...... n: the Cardiovascular Polypill

@en

P2093

D E Grobbee

http://www.w3.org/2001/XMLSchema#string

M Lafeber

http://www.w3.org/2001/XMLSchema#string

W Spiering

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Multiple risk factor interventions for primary prevention of coronary heart disease

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

A strategy to reduce cardiovascular disease by more than 80%

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

P2888

s11906-016-0648-3

P304

40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2921137

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11906-016-0648-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Frank L Visseren

P5008

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050812225

http://www.w3.org/2001/XMLSchema#string

P698

27083928

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

arterial hypertension

P932

4833798

http://www.w3.org/2001/XMLSchema#string